Organ-on-Chip Technology + Multicellular 3D Disease Model Development and Artificial Intelligence provides spatiotemporal profiling and analysis of drug testing and treatment at a cellular level.
Our microfluidic-based Organ-on-Chip technology recapitulates the multicellular microenvironment of the organ, providing an excellent in vitro model suitable for drug discovery.
Downstream morphological, secretory, and multi-omics profiling of these complex organ models using AI and machine learning analysis, allows the development of multiplexed profiles of different cellular populations, permitting the detection of subtle biologically relevant responses and phenotypes.
Our Data Science and AI Platform provides downstream morphological, secretory, and multi-omics profiling of complex organ models using AI and machine learning analysis, enabling the development of multiplexed profiles of different cellular populations, permitting the detection of subtle biologically relevant responses and phenotypes.
Our organ-on-chip technology has demonstrated cost and time savings while better replicating human physiological conditions. Current methods, including 2D Cell Culture, 3D Cell Culture and Animal Models have proven limitations when compared to Organ-on-Chip platforms.
ADVANTAGES
LIMITATIONS
ADVANTAGES
LIMITATIONS
ADVANTAGES
LIMITATIONS
Establish new disease models for research and drug testing applications
Perform technical validation and multi-center validation to build confidence in the model’s predictive performance, data quality, and robustness
Establish guidelines and standards to incorporate Organ Chip and AI technologies in regulatory submission and approval
Promote the use of Organ Chip Models in Safety Assessment and Precision Medicine
Leave us a request and we will contact you soon.